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Abstract 
 
Indonesian National Committee for human immunodeficiency virus (HIV) and acquired immune deficiency syndrome 
(AIDS) has reported the significant increase of HIV infected individual in Indonesia. A sensitive accurate diagnostics 
are urgently needed to prevent the dissemination of HIV and also to provide a suitable therapy. For this reason, we have 
developed HIV diagnostic method based on PCR to elucidate this problem. For this research, samples were collected 
from hospitals and Indonesian Red Cross that consist of samples possesing HIV serological test positive and 
indeterminate. Ribonucleic Acid (RNA) were isolated from blood plasma. These RNA then were amplified after 
Reverse transcriptase reaction by using primers which have been designed using env (C2V3C3), Long Terminal 
Repeats (LTR) (U3) and Capsid gag (p24) as target regions. The obtained results shown 26/34 (76.5%) positive in LTR, 
10/33 (36.4%) positive in Env and 11/33 (33.3%) positive in p24. These results showed that LTR primers detect HIV 
more than other primers. It suggests that LTR could be used as detection target as complement of env and p24 These 
results need to be explored further by using sequencing method. 
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Introduction 
 
In Indonesia, human immunodeficiency virus/acquired 
immune deficiency syndrome (HIV/AIDS) cases are 
increasing significantly in the last recent years. This 
increase caused majority by the increasing of IDU users 
in Indonesia. The emerging HIV epidemics in countries 
of Asia and Eastern Europe will contribute significantly 
to the future of the HIV pandemic. An aggressive action 
is required either in prevention as developmet 
diagnostic methods, vaccines etc. or in treatment as the 
developments of antivirals using various substance etc. 
to prevent pandemi.1,2 
 
Since 1986, a number and variety of commercial assays 
have been available to screen blood, diagnose infection, 
and monitor disease progression in individuals infected 
by human immunodeficiency virus types 1 and 2 (HIV-
1 and HIV-2). These assays are categorized in four main 
classes, including tests that detect HIV antibody, detect 
p24 antigen, detect or quantify viral nucleic acids, and 
estimate T-lymphocyte numbers (cell phenotyping). The 
enzyme-linked immunosorbent assay (ELISA) is the 
most common immunoassay utilized for the detection of 
HIV antibody and antigen. This technique has evolved from 
the first-generation viral lysate-based immunoglobulin G 
(IgG) tests, to the second-generation tests incorporating 
recombinant and/or synthetic peptide antigens, to the 
third-generation tests which detect IgG and IgM 
(antigen sandwich techniques), and finally to the third-
generation-plus assays which also detect HIV-1 group O.3 
 
HIV diagnostics by using RT-PCR (Reverse transcriptase 
polymerase chain reaction) have been developed to 
increase the sensitivity of HIV detection.4-6 Affordable 
RT-PCR method is required for HIV prevention and 
antiretroviral treatment programs. Since many non-B 
subtypes, circulating recombinant forms and unique 
recombinant forms circulate in these areas, in-house 
HIV-1 RNA RT-PCR assays are ideal academic tools to 
thoroughly evaluate the impact of HIV-1 genetic 
diversity on the accuracy of HIV-1 RNA quantification, 
as compared with licensed techniques.4 
 
This research aimed to develop HIV diagnostic method 
based on Circulating HIV strains in Indonesia to obtain 
more accurate and affordable HIV diagnostic methods. 
 
Methods 
 
In this research, blood samples possesing HIV 
serological test positive and indeterminate were collected 
from Indonesia Red Cross (PMI) Blood Transfusion 
Centre (UTDP) Jakarta. Meanwhile, blood samples with 
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the same criteria also were collected from patients 
having HIV clinical manifestation. By using Viral RNA 
isolation kit, HIV RNA were isolated from blood plasma. 
Target genes then were amplified by using appropriate 
primers that were designed prior to this research. These 
designed primers will be developped for HIV diagnostic 
with focus on circulating HIV in Indonesia. 
 
Samples were collected from Indonesian Red Cross and  
hospitals. Samples collected were samples possessing 
HIV serological test positive and indeterminate. 
Samples were tested by using western blot for 
confirmation. 
 
Viral RNA were extracted from blood plasma sample by 
using a RNA isolation kit. Viral RNA were then used 
for RT-PCR by using an appropriate primers which 
have been design previously. Primers were designed 
based on HIV sequences obtained from HIV 
compendium, published by NIH (National Insititute of 
Health) with focus on HIV subtype in Thailand which is 
supposed closed to HIV strain in Indonesia. 
Amplification were performed in env (C2V3C3), LTR 
(U3)l and Capsid gag (protein p24) regions. PCR 
product were separated by electrophoresis on a 12% 
polyacrylamide gel. The gels were then stained with 
ethidium bromide and visualized under a UV 
transilluminator.  
 
Results and Discussion 
 
For this research, total samples of 34 were collected that 
consist of 12 samples from HIV positive patients, 1 
sample from HIV indeterminate patient, 11 samples 
from HIV positive blood donor and 10 samples from 
HIV indeterminate blood donor. Ribonucleic acid 
(RNA) form blood plasma were isolated from each 
sample by using viral RNA extraction (Qiagen). These 
RNA were used for RT-PCR reaction template by using 
One-Step RT-PCR (Qiagen). Virion RNA reflects 
currently replicating virus and thus has more pathogenic 
significance than the proviral DNA present in PBMC 
(Pheripheral Blood Mononuclear Cells). Proviral DNA 
contains high levels of integrated defective viral 
sequences. However, using RNA as the template has 
technical difficulty because of RNA unstability.7 RT-
PCR results in HIV positive patient samples showed 
10/12 (83%) positive in LTR, 3/7 (42%) positive in env 
and 3/12 (25%) positive in p24. Sample from patient 
having HIV serological test indeterminate cannot be 
detected in all gene target regions. Whereas in HIV 
positive blood donor samples 11/11 (100%), 7/10 (70%) 
and 8/10 (80%) positive bands in LTR, env and p24, 
respectively, were detected. On the contrary, HIV 
indeterminate blood donor samples only can be detected 
5/10 (50%) in LTR region. In total samples, 26/34(76.5%), 
10/33 (36.4%) and 11/33 (33.3%) can be detected in 
LTR, env and p24, respectively. It means that LTR 
detect more samples than other target regions. P24 is 
commonly used as a target for HIV detection method 
because it is a conserved region.8,9 Eventhough, the use 
of another target region as LTR may necessary to improve 
 
 
               
 
Figure 1. The Amplification of LTR Region (351bp) by 
Using RT-PCR. PCR Product were Detected by 
Electrophoresis on 12 % Acrylamide Gel and 
Visualized by Ethidium Bromide. Column 1: 
Pos Blood Donor 1, Column 2: Ind. Blood Donor 
1, Column 3: Ind Blood Donor 2, Column 4: Ind 
Blood Donor 3, Column 5: Ind Blood Donor 4, 
Column 6: Ind Blood Donor 5, Column 7: Pos 
Patient 5, Column 8: Pos Patient 6, Column 9: 
Pos Patient 7, Column 10: Pos Patient 8, 
Column 11: Pos Patient 9. Column 12: Pos 
Patient 10. Column 13: Pos Patient 11, Column 
14: Negatif Control. M: 100bp Marker  
 
 
 
       
 
Figure 2. The Amplification of p24 Region (705 bp) by 
Using RT-PCR. PCR Product were Detected by 
Electrophoresis on 12 % Acrylamide Gel and 
Visualized by Ethidium Bromide. Column 1: 
Negatif Control, Column 2: Positif Control, 
Column 3: Pos Patient 9, Column 4: Pos Patient 
10, Column 5: Pos Patient 11, Column 6: Positif 
Control, Column 7: Positif Control, Column 8: 
Negatif Control, Column 9: Pos Blood Donor 2, 
Column 10: Pos Blood Donor 3, Column 11: Pos 
Blood Donor 4, Column 12: Pos Blood Donor 5, 
Column 13: Pos Blood Donor 6, Column 14: Pos 
Blood Donor 7, Column 15: Pos Blood Donor 8, 
Column 16: Pos Blood Donor 9. Column 17: Pos 
Blood Donor 10, Column 18: Pos Blood Donor 11  
M     1     2      3     4     5     6      M     7    8    9    10  11  12  13  14  15 16 17 18    
705 bp 
351bp 
1    2    3    4    5    6   M   7   8   9   10  11  12 13  14    
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Figure 3.  The Amplification of Env Region (681 bp) by 
Using RT-PCR. PCR Product were Detected by 
Electrophoresis on 12 % Acrylamide gel and 
visualized by Ethidium Bromide. Column 1: 
Negatif Control. Column 2: Positif Control. 
Column 3: Pos Blood Donor 10, Column 4: Pos 
Blood Donor 11, Column 5: Pos Blood Donor 12, 
Column 6: Pos Blood Donor 13, Column 7: Pos 
Blood Donor 14, Column 8: Pos Blood Donor 15, 
Column 9: Pos Blood Donor Pos 16 
 
 
improve the performance of HIV diagnostic. It has been 
reported that the LTR-based HIV-1 RNA RT-qPCR has 
been evaluated for HIV diagnostic. The usefulness of 
this method has been clearly demonstrated for early 
diagnosis of pediatric HIV-1 infection and monitoring.6 
 
LTR region is potential to be developed as target 
regions of HIV diagnostic as complement of p24 and 
env. Further experiments should be performed to 
elucidate the problem of undetectable samples in p24 
and env regions. Sequencing method will be necessary 
to analyze the annealing of each primer and also to 
analyze the possibility of mutation and escape mutant 
that may be present in circulating HIV strain in 
Indonesia. 
 
Conclusion 
 
LTR region is potential to be developed as target region 
of HIV diagnostic by using RT-PCR as complement of 
p24 and env target region. Results that showed the small 
percentage of positive bands in p24 and env target 
regions need to be explored further to know the 
possibility of mutations and escape epitopes. Primers 
that have been developed in this research require further 
optimization especially on the annealing site of each 
primer to improve the accuracy and sensitivity of this 
method.  
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